Marinomed Biotech AG

Declaration of Voting Results & Voting Rights Announcements • Oct 18, 2019

Publication Date: 18.10.2019 17:00 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Overview 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Acquisition or disposal of voting rights 3. Person subject to notification obligation Name: Republik Österreich City: Österreich Country: Österreich 4. Name of shareholder(s): aws Mittelstandsfonds Beteiligungs GmbH & Co KG 5. Date on which the threshold was crossed or reached: 18.10.2019

1. Total positions

____________
		% of voting
	% of voting			rights through Total of both Total number of
	rights attached financial/other in % (7.A +			voting rights
	to shares (7.A) instruments		7.B)	of issuer
		(7.B.1 + 7.B.2)
__ __ __ __ __
Resulting
situation on
the date on
which threshold	3.19 %	0.00 %	3.19 %	1 469 772
was crossed /
reached
__ __ __ __ __
Position of
previous
notification	8.47 %
(if applicable)
__ __ __ __ __

Details

1. Notified details of the resulting situation:

	____________ A: Voting rights attached to shares
	___________ ____ ____	Number of voting rights			% of voting rights
	Direct	Indirect		Direct			Indirect
ISIN Code	(Sec 130 BörseG (Sec 133 BörseG (Sec 130 BörseG (Sec 133 BörseG
	2018)	2018)		2018)			2018)
ATMARINOMED6	___ ___ ___ ___ __	46 816						3.19 %
SUBTOTAL A	___ ___ ___ ___ __ 46 816 ___ _____ ________				3.19 %

______________________________________________________________________________

			____________
			Number of voting
			rights that may
			be
Type of			Expiration Date Exercise Period acquired if the	% of voting
instrument			instrument is	rights
			exercised
			___ ___ ___ ___ __
			___ ___ ___ ___ __
		SUBTOTAL B.1
			___ ___ ___ ___ __

2018				___________ B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG ___________
Type of	Expiration Exercise		Physical / Cash	Number of	% of voting
instrument	Date	Period	Settlement	voting rights __ _ __ _ _ _	rights
			SUBTOTAL B.2	__ _ __ _ _ _ __ _ __ _ _ _

1. Information in relation to the person subject to the notification obligation: Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

	____________			Financial/
		Directly	Shares held	other
No.	Name	controlled directly		instruments	Total of
		by No.	(%)	held	both (%)
				directly
	_ __ __ _ _(%)_ ______
	Republik
1	Österreich
	_ __ __ _ __ ___
	Austria
2	Wirtschaftsservice	1
	GmbH
	_ __ __ _ __ ___
	aws
3	Fondsmanagement	2
	GmbH _ __ __ _ __ ___
	aws
	Mittelstandsfonds
4	Beteiligungs GmbH	3	3.19 %		3.19 %
	& Co KG
	_ __ __ _ __ ___

1. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights.

2. additional comments:

Correction of the notification originally sent on 16.10.2019 with regard to the date on which the threshold was reached (value date instead of date of transaction - transaction concluded on 16.10.2019, value date/setting date took place on 18.10.2019).

Note of the Issuer: This is a translation of the received shareholder notification in German language. The translation into English is not binding.

Further inquiry note:

Dr. Eva Prieschl-Grassauer Chief Scientific Officer, Marinomed Veterinärplatz 1, 1210 Vienna, Austria T +43 (0)1 250 77 4460 E-Mail: eva.prieschl@marinomed.com http://www.marinomed.com

Roland Mayrl Managing Partner, Metrum Communications Bauernmarkt 10/19, 1010 Vienna, Austria T +43 (0) 1 504 69 87 331 E-Mail: r.mayrl@metrum.at http://www.metrum.at

end of announcement euro adhoc --------------------------------------------------------------------------------

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

Aussendung übermittelt durch euro adhoc The European Investor Relations Service